Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
Kimberly Noonan, Ph.D., is a scientific co-founder of WindMIL along with Ivan Borrello, M.D. Together Dr.’s Borrello and Noonan pioneered the use of marrow infiltrating lymphocytes (MILs) for the treatment of cancer. Dr. Noonan received her BS in Microbiology and PhD in Immunology from the University of Pittsburgh. She also holds an MPH from Johns Hopkins University. Dr. Noonan has published many peer-reviewed papers, review articles, and book chapters and holds several patents. She joined the faculty of Johns Hopkins University in 2004 and maintains an adjunct faculty appointment. Currently, she is the Executive Vice President & Chief Scientific Officer at WindMIL Therapeutics.